Drugs: E

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z #

Ergotamine Tartrate and Caffeine

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Ergotamine Derivative [EPC]; Ergotamines [CS]; Methylxanthine [EPC]; Xanthines [CS]

0 identified pills

Erlotinib Hydrochloride

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

0 identified pills

Ertugliflozin

0 identified pills

Escitalopram

Pharmacologic Class: Selective serotonin reuptake inhibitor (SSRI)

291 identified pills

Escitalopram Oxalate

Serotonin Reuptake Inhibitor [EPC]; Serotonin Uptake Inhibitors [MoA]

0 identified pills

Escitslopram

Serotonin Reuptake Inhibitor [EPC]; Serotonin Uptake Inhibitors [MoA]

0 identified pills

Esomeprazole

A "proton pump inhibitor (PPI)" that "suppress[es] gastric acid secretion by specific inhibition of the H+/K+ ATPase enzyme system" in the gastric parietal cell, blocking the final step of acid production in a dose-dependent manner.

231 identified pills

Esomeprazole DR

Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

0 identified pills

Esomeprazole Magnesium 20mg

Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

0 identified pills

Esomeprazole Magnesium Delayed-Release 20 mg (OTC)

Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

0 identified pills

Esomeprazole Magnesium Delayed-Release Capsules, 20 mg

Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

0 identified pills

Esomeprazole magnesium delayed release capsules

Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

0 identified pills

Estazolam

Benzodiazepine [EPC]; Benzodiazepines [CS]

0 identified pills

Esterified Estrogens and Methyltestosterone

Androgen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]

0 identified pills

Estradiol

The principal endogenous human estrogen, which "acts through binding to nuclear receptors in estrogen-responsive tissues," modulating the pituitary secretion of gonadotropins (LH/FSH) through negative feedback and exerting effects on bone, the reproductive tract, and other estrogen-responsive tissues.

1061 identified pills

Eszopiclone

A "nonbenzodiazepine hypnotic agent that is a pyrrolopyrazine derivative of the cyclopyrrolone class." Its effect is "believed to result from its interaction with GABA-receptor complexes at binding domains located close to or allosterically coupled to benzodiazepine receptors."

170 identified pills

Ethambutol Hydrochloride

Antimycobacterial [EPC]

0 identified pills

Etodolac

A "member of the pyranocarboxylic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs)." Its mode of action, like other NSAIDs, "may be related to prostaglandin synthetase inhibition."

185 identified pills

Etrasimod

Sphingosine 1-Phosphate Receptor Modulators [MoA]; Sphingosine 1-phosphate Receptor Modulator [EPC]

0 identified pills

Etravirine

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

0 identified pills

Everolimus tablets

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

0 identified pills

Exemestane

Aromatase Inhibitor [EPC]; Aromatase Inhibitors [MoA]

0 identified pills

Extended Phenytoin Sodium

Anti-epileptic Agent [EPC]; Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 2D6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

0 identified pills

Extra Strength Pain Relief

0 identified pills

Eye health capsule

Allergens [CS]; Amino Acid Hypertonic Solution [EPC]; Amino Acids [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]

0 identified pills

elafibranor

Cytochrome P450 3A4 Inducers [MoA]; Peroxisome Proliferator-activated Receptor Agonist [EPC]; Peroxisome Proliferator-activated Receptor Agonists [MoA]

0 identified pills

eliglustat

Cytochrome P450 2D6 Inhibitors [MoA]; Glucosylceramide Synthase Inhibitor [EPC]; Glucosylceramide Synthase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

0 identified pills

elinzanetant

0 identified pills

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitor [EPC]; Cytochrome P450 3A Inhibitors [MoA]; HIV Integrase Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

0 identified pills

elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitor [EPC]; Cytochrome P450 3A Inhibitors [MoA]; HIV Integrase Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

0 identified pills

empagliflozin and linagliptin

Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

0 identified pills

empagliflozin and metformin hydrochloride

Biguanide [EPC]; Biguanides [CS]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

0 identified pills

empagliflozin, linagliptin, metformin hydrochloride

Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

0 identified pills

empagliflozin, metformin hydrochloride

Biguanide [EPC]; Biguanides [CS]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

0 identified pills

emtricitabine and tenofovir alafenamide

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]

0 identified pills

emtricitabine, rilpivirine and tenofovir disoproxil fumarate

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]

0 identified pills

emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]

0 identified pills

emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]

0 identified pills

enalapril maleate and hydrochlorothiazide

Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Decreased Blood Pressure [PE]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

0 identified pills

enasidenib mesylate

Isocitrate Dehydrogenase 2 Inhibitor [EPC]; Isocitrate Dehydrogenase 2 Inhibitors [MoA]

0 identified pills

ensartinib

0 identified pills

ertugliflozin and metformin hydrochloride

Biguanide [EPC]; Biguanides [CS]

0 identified pills

ertugliflozin and sitagliptin

Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

0 identified pills

eslicarbazepine acetate

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

0 identified pills

esomeprazole magnesium capsule, delayed release

Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

0 identified pills

esomeprazole magnesium dihydrate

Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

0 identified pills

esomeprazole strontium

Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

0 identified pills

estradiol/norethindrone acetate

Estradiol Congeners [CS]; Estrogen Receptor Agonists [MoA]; Estrogen [EPC]; Progesterone Congeners [CS]; Progestin [EPC]

0 identified pills